India expects the U.S. team to visit India for next round of trade talks, say officials

India expects a US trade delegation to visit India for the next round of trade negotiations, following the February 7, 2026 joint statement that finalised a ...

What Happened

India expects a US trade delegation to visit India for the next round of trade negotiations, following the February 7, 2026 joint statement that finalised a framework for an interim trade agreement.
The February 7, 2026 India-US Joint Statement committed both sides to reciprocal and mutually beneficial trade, with the US applying a reciprocal tariff rate of 18% on originating Indian goods across several categories.
Subject to conclusion of the full Interim Agreement, the US agreed to remove reciprocal tariffs on a wider range of Indian goods including generic pharmaceuticals, gems and diamonds, and aircraft parts.
India committed in return to address barriers to US medical devices, eliminate restrictive import licensing on ICT goods, and reduce tariff barriers on a range of US products.
The broader objective is a Bilateral Trade Agreement (BTA) that would address tariffs, non-tariff barriers, services, investment, intellectual property, government procurement, and state-owned enterprise practices.
Officials expect the US team to visit India for the next round before the end of May 2026, ahead of a further visit by the US Secretary of State later in the month.

Static Topic Bridges

India-US Trade Relations: Structural Overview

India and the United States are each other's major trade partners, with bilateral goods and services trade exceeding USD 190 billion in 2023–24. The relationship has historically been characterised by a goods trade surplus in India's favour (India exports more goods to the US than it imports), offset by a services trade deficit (the US exports more services). Key friction points have included India's import tariffs (among the higher average tariffs of large economies), US concerns about intellectual property protection and market access for agricultural products and ICT goods, and India's use of import licensing and procurement preferences. A Generalized System of Preferences (GSP) arrangement that allowed duty-free access for certain Indian exports to the US was terminated in 2019; its restoration or replacement has been a recurring trade diplomacy objective.

India is the US's 9th largest goods trading partner; the US is India's largest goods export destination.
India's goods exports to the US: approximately USD 83–87 billion (FY 2024–25); India's goods imports from the US: approximately USD 40–45 billion.
India's average applied tariff (MFN) is approximately 17%, one of the higher levels among G20 economies.
The US imposed a "reciprocal tariff" of 26% on Indian goods in April 2025 under the Trump administration's tariff agenda; the February 2026 framework reduced this to 18% for covered categories.
The February 2026 Joint Statement is described as a "historic trade deal" framework — the first structural tariff agreement between India and the US.

Connection to this news: The ongoing trade talks represent the most consequential India-US economic engagement in decades, with the potential to restructure the bilateral trade architecture and significantly expand India's access to the world's largest consumer market.

Reciprocal Tariffs and WTO Framework

A reciprocal tariff is a tariff imposed by one country in direct response to — and at the same level as — the tariff levied by a trading partner. The Trump administration's 2025 "reciprocal tariff" policy framed US tariff reductions as contingent on trading partners reducing their own barriers to US goods. This approach operates in tension with WTO's Most Favoured Nation (MFN) principle, which requires that tariff concessions granted to one trading partner be extended equally to all WTO members. Bilateral trade agreements are exempt from the MFN principle under GATT Article XXIV (for goods) and GATS Article V (for services), provided they cover "substantially all trade" between the partners.

WTO MFN Principle: A cornerstone of the multilateral trading system requiring that trade benefits extended to one partner be extended to all WTO members.
GATT Article XXIV: Exception to MFN that permits bilateral and regional FTAs, subject to conditions (coverage of substantially all trade, no increase in barriers to third parties).
India joined the WTO on January 1, 1995 (founding member).
The Trump administration's reciprocal tariff framework imposed country-specific tariffs based on perceived asymmetries, which India — with higher average tariffs — was particularly exposed to (original rate: 26%).
The 18% rate under the February 2026 framework represents a significant reduction but is still above the 0% rate India would prefer for its key export categories.

Connection to this news: The India-US interim agreement framework represents a bilateral workaround to WTO MFN obligations — structurally permissible under GATT Article XXIV but politically significant as it marks a departure from the multilateral tariff system toward managed bilateral reciprocity.

India's Export Economy: Key Sectors at Stake

India's goods exports to the US are concentrated in a few high-stakes sectors: generic pharmaceuticals (India supplies approximately 40% of US generic drug requirements), textiles and apparel, gems and jewellery, engineering goods, chemicals, and IT services (separately). The US market's importance to these sectors makes the trade agreement framework directly consequential for Indian employment and industrial competitiveness.

Generic pharmaceuticals: India is the US's single largest supplier by volume; approximately 40% of generics and 10% of all prescription drugs in the US are of Indian origin. Removal of reciprocal tariffs on generics under the interim framework is economically significant.
Gems and diamonds: India (particularly the Surat cutting and polishing industry) is a dominant player; tariff removal benefits this labour-intensive sector.
Textiles and apparel: Among the categories facing the 18% reciprocal tariff rate; any reduction improves India's competitiveness against Bangladesh and Vietnam.
Medical devices: The US wants India to eliminate non-tariff barriers (price controls, local content requirements) on medical devices — a key concession India agreed to in the February 2026 framework.
ICT goods: India agreed to eliminate restrictive import licensing on US ICT products — addressing a longstanding US complaint.

Connection to this news: The next round of talks in India is expected to advance these sector-specific commitments from framework to binding agreement, with generic pharmaceuticals and textile tariff removal being the most economically significant items for India.

Key Facts & Data

India-US Joint Statement date: February 7, 2026 — framework for interim trade agreement (Bilateral Trade Agreement / BTA).
Reciprocal tariff applied on Indian goods under Trump's 2025 tariff action: originally 26%; reduced to 18% under the 2026 framework for covered categories.
Tariff removal committed for: generic pharmaceuticals, gems and diamonds, aircraft parts (US side).
India's commitments: address barriers to US medical devices, eliminate restrictive import licensing on ICT goods, reduce tariffs on a range of US products.
India's goods exports to the US: approximately USD 83–87 billion (FY 2024–25); US is India's largest goods export destination.
India supplies approximately 40% of US generic drug requirements.
India's average applied MFN tariff: approximately 17% — among the higher levels in the G20.
India joined WTO: January 1, 1995.
Full BTA to address: tariff barriers, non-tariff barriers, services, investment, IP, labour, environment, government procurement, and SOE practices.